GO:0042307 positive regulation of protein import into nucleus: Nucleocytoplasmic Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042307 describes any process that activates or increases the movement of proteins from the cytoplasm into the nucleus [1, 3].
• Positive regulation of nuclear import is essential for signal-dependent gene expression, cell division, and stress responses [1, 4].
• Key regulatory nodes include importin adaptors, RanGTP gradients, and post-translational modifications of cargo or carriers [3, 5].
• Dysregulation of nuclear import contributes to cancer, neurodegeneration, and premature aging syndromes [4, 6, 7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of nuclear import regulators [2, 5, 8].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:0042307 in disease contexts.
Description
Positive regulation of protein import into nucleus (GO:0042307) is a biological process that increases the frequency, rate, or extent of protein translocation from the cytoplasm into the nucleus [1, 3]. This process is fundamental to eukaryotic cell biology because it controls the timely delivery of transcription factors, signaling effectors, and metabolic enzymes to their nuclear targets [3, 5]. For researchers, GO:0042307 provides a framework to study how cells convert cytoplasmic signals into nuclear responses, including cell division, autophagy, and immune activation [1, 3, 5]. The term encompasses both the activation of nuclear import machinery and the regulated movement of specific cargo proteins across the nuclear envelope [4, 8]. Understanding its molecular players and regulatory logic is critical for interpreting gene expression programs in health and disease [2, 6, 7].
positive regulation of protein import into nucleus At A Glance
| GO ID | GO:0042307 |
|---|---|
| GO term | positive regulation of protein import into nucleus |
| Ontology | biological_process |
| Synonym | activation of protein import into nucleus; positive regulation of protein-nucleus import; stimulation of protein import into nucleus; upregulation of protein import into nucleus |
| Major function | Increases the rate or extent of protein translocation from cytoplasm to nucleus |
| Related processes | Nucleocytoplasmic transport, signal transduction, cell cycle regulation, autophagy |
| Key regulators | Importin adaptors, RanGTP, post-translational modifications, chaperones |
| Disease relevance | Cancer, neurodegeneration, progeria, immune disorders |
What Is GO:0042307?
GO:0042307 is defined as any process that activates or increases the frequency, rate, or extent of the movement of proteins from the cytoplasm into the nucleus [1, 3]. It includes the positive regulation of protein-nucleus import, protein transport from cytoplasm to nucleus, and related synonyms such as stimulation or upregulation of nuclear protein import [4, 5]. This term is a child of positive regulation of protein transport and is distinct from constitutive nuclear import; it specifically captures regulatory events that enhance import efficiency or capacity [3, 8].
Why Is positive regulation of protein import into nucleus Important in Cell Biology?
Positive regulation of protein import into nucleus is important because it determines how quickly and selectively cells can deliver cytoplasmic signals to the nucleus, thereby shaping gene expression programs [1, 3]. Many oncogenic and developmental pathways depend on enhanced nuclear import of transcription factors and metabolic enzymes [3, 6]. Conversely, impaired nuclear import is linked to neurodegeneration and premature aging [4, 7]. Thus, GO:0042307 is a central node for understanding cellular decision-making and for identifying therapeutic targets [2, 5, 8].
• Controls signal-dependent nuclear translocation of transcription factors such as STAT1 and NF-kB.
• Regulates cell division by promoting nuclear import of cell cycle regulators.
• Supports autophagy and lysosomal biogenesis through nuclear ACSS2.
• Modulates mTORC1 signaling via p300 nucleocytoplasmic shuttling.
• Contributes to immune effector T cell programs through non-canonical STAT1 import.
• Dysregulated in cancers with ErbB receptor alterations.
• Impaired in SOD1-mediated ALS and other neurodegenerative conditions.
• Affects mRNA biogenesis through NCBP3 nuclear functions.
• Provides targets for CRISPR-based functional genomics [2, 8].
• Enables therapeutic strategies to modulate nuclear import in disease [4, 5].
What Happens During positive regulation of protein import into nucleus?
Signal recognition and cargo activation
In simple terms: A signal tells the cell to move a specific protein into the nucleus.
Positive regulation begins when extracellular or intracellular signals modify cargo proteins or their import receptors, increasing their affinity for nuclear transport [1, 3]. For example, cytokinin signaling in Arabidopsis activates cell division by promoting nuclear import of key regulators. Similarly, ACSS2 is translocated to the nucleus under specific metabolic conditions to promote gene transcription.
Importin-cargo complex assembly
In simple terms: The cargo protein binds to a carrier that will take it through the nuclear pore.
Importin alpha and beta adaptors recognize nuclear localization signals (NLS) on cargo proteins, forming a ternary complex that is competent for nuclear pore transit [5, 8]. Positive regulation can increase the availability or activity of these adaptors, as seen when PDIA3 acts as a chaperone to facilitate non-canonical nuclear import of STAT1 and PKM2.
Nuclear pore translocation and RanGTP gradient
In simple terms: The carrier-cargo complex passes through the nuclear pore, powered by a chemical gradient.
The complex moves through the nuclear pore complex, and inside the nucleus, RanGTP binds importin to release the cargo [4, 8]. Positive regulation of this step can involve modulation of RanGTP levels or nucleoporin modifications, as observed in p300 nucleocytoplasmic shuttling under mTORC1 hyperactivation.
Cargo release and nuclear retention
In simple terms: Once inside, the protein is released and stays in the nucleus to do its job.
After release, cargo proteins may be retained in the nucleus through interactions with nuclear components or post-translational modifications that prevent re-export [3, 5]. This retention is critical for sustained transcriptional responses, such as ACSS2-mediated lysosomal biogenesis and autophagy.
Feedback and termination
In simple terms: The cell can shut down the import signal when it is no longer needed.
Positive regulation is balanced by negative feedback mechanisms that degrade or re-export cargo, or downregulate import adaptors [4, 8]. For instance, impaired nucleocytoplasmic transport in SOD1-mediated ALS suggests that disruption of this balance contributes to disease.
Key Genes Involved in GO:0042307 positive regulation of protein import into nucleus
The following genes and proteins are experimentally implicated in positive regulation of protein import into nucleus (GO:0042307) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACSS2 | Nuclear translocated enzyme promoting gene transcription for lysosomal biogenesis and autophagy | Metabolic regulation of nuclear import |
| STAT1 | Transcription factor with non-canonical nuclear import facilitated by PDIA3 | Immune effector T cell programs |
| PKM2 | Glycolytic enzyme with nuclear functions, imported via PDIA3 chaperone | Cancer metabolism and immune regulation |
| PDIA3 | Chaperone facilitating non-canonical nuclear import of STAT1 and PKM2 | Target for modulating nuclear import in T cells |
| p300 | Transcriptional coactivator that shuttles between nucleus and cytoplasm | mTORC1 hyperactivation in progeria |
| SOD1 | Mutant forms impair nucleocytoplasmic transport | ALS neurodegeneration |
| NCBP3 | Nuclear protein positively impacting mRNA biogenesis | RNA processing and nuclear import |
| ErbB receptors | Cell surface receptors that signal to nuclear import pathways | Cancer progression |
| Cytokinin receptors | Plant hormone receptors activating cell division via nuclear import | Plant developmental biology |
| Ran | GTPase establishing gradient for nuclear transport | Core transport machinery [4, 8] |
| Importin alpha | Adaptor recognizing nuclear localization signals | Cargo selection [5, 8] |
| Importin beta | Carrier mediating nuclear pore transit | Transport regulation [4, 8] |
| Nucleoporins | Components of nuclear pore complex | Transport channel [4, 7] |
| mTORC1 | Kinase complex regulating p300 shuttling | Growth signaling |
| Somatic metabolism genes | Mutations in chronic liver disease affecting nuclear processes | Liver disease |
How Is positive regulation of protein import into nucleus Regulated?
Positive regulation of protein import into nucleus is controlled by multiple signaling inputs, including mTORC1, which modulates p300 nucleocytoplasmic shuttling. Post-translational modifications such as phosphorylation and acetylation alter cargo-importin affinity [3, 5]. Chaperones like PDIA3 facilitate non-canonical import of specific cargoes. In plants, cytokinin signaling activates cell division by promoting nuclear import of key regulators. Dysregulation of these pathways is linked to cancer, neurodegeneration, and metabolic disease [2, 6, 7].
positive regulation of protein import into nucleus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACSS2 | Cancer metabolism and autophagy | Knockout and overexpression in cancer cell lines |
| STAT1 | Immune disorders and cancer | Point mutation of import residues |
| p300 | Hutchinson-Gilford progeria syndrome | Knock-in of progerin in fibroblasts |
| SOD1 | Amyotrophic lateral sclerosis | Knock-in of SOD1 mutations in neurons |
| NCBP3 | mRNA biogenesis defects | Knockout in HEK293 cells |
Cancer
Enhanced nuclear import of oncogenic transcription factors and metabolic enzymes drives tumor progression [3, 6]. ErbB receptor signaling can promote nuclear translocation of effectors that support proliferation. Targeting positive regulation of nuclear import may offer therapeutic opportunities [3, 5].
Neurodegeneration
Impaired nucleocytoplasmic transport is a hallmark of SOD1-mediated ALS, where mutant SOD1 disrupts nuclear import pathways. This suggests that restoring positive regulation of nuclear import could be neuroprotective.
Premature aging
In Hutchinson-Gilford progeria syndrome, mTORC1 hyperactivation alters p300 nucleocytoplasmic shuttling, contributing to disease phenotypes. Modulating nuclear import may ameliorate progerin-induced defects.
Chronic liver disease
Convergent somatic mutations in metabolism genes, including those affecting nuclear processes, are found in chronic liver disease. These mutations may alter positive regulation of nuclear import.
From positive regulation of protein import into nucleus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate nuclear import of cargo Y? | Knockout cell line with nuclear import reporter [3, 5] |
| Does a point mutation in cargo Y alter its nuclear import? | Point mutation knock-in via CRISPR |
| Can a tag on importin reveal real-time transport? | Tagged knock-in of importin beta [4, 8] |
| Does overexpression of gene X enhance nuclear import? | Overexpression cell line [3, 6] |
| Which genes regulate nuclear import in a genome-wide manner? | CRISPR library screening [2, 8] |
| Does a disease mutation affect nuclear import? | Patient-derived iPSCs with knock-in [4, 7] |
How to Study the positive regulation of protein import into nucleus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GFP-cargo imaging | Nuclear import kinetics and localization | Live-cell imaging of STAT1 import |
| Affinity proteomics | Importin-cargo interactions | Identifying PDIA3-STAT1 complexes |
| RNA-seq | Transcriptional output of nuclear import | ACSS2-dependent autophagy genes |
| CRISPR knockout screen | Genes required for nuclear import | Genome-wide regulators [2, 8] |
| CRISPR activation screen | Genes that enhance nuclear import | Positive regulators |
| Proximity labeling | Transient nuclear import complexes | p300 shuttling |
| Phosphoproteomics | Signaling modifications on cargo/importins | mTORC1 regulation |
| Single-molecule tracking | Nuclear pore transit dynamics | SOD1 ALS models |
Imaging-based nuclear import assays
Fluorescence microscopy of GFP-tagged cargo proteins allows real-time monitoring of nuclear import rates and subcellular localization [3, 5]. High-content imaging can quantify positive regulation in response to stimuli.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry identifies importin-cargo complexes and post-translational modifications that regulate nuclear import [5, 8]. Proximity labeling can capture transient interactions.
Transcriptomics and RNA-seq
RNA sequencing reveals gene expression changes downstream of nuclear import events, such as ACSS2-dependent lysosomal biogenesis. It can also identify feedback regulators [1, 8].
CRISPR screening
Genome-wide CRISPR knockout or activation screens with nuclear import reporters identify positive regulators of GO:0042307 [2, 8]. These screens can be performed in disease-relevant cell types.
How CRISPR Can Be Used to Study GO:0042307 positive regulation of protein import into nucleus
Knockout
CRISPR knockout of candidate genes such as ACSS2 or PDIA3 can abolish positive regulation of nuclear import, revealing essential regulators [3, 5]. Knockout cell lines are ideal for loss-of-function studies in disease models.
Point Mutation
Introducing point mutations in nuclear localization signals or importin-binding domains of cargo proteins (e.g., STAT1) allows precise dissection of import regulation. This approach can mimic disease-associated mutations.
Knock-in
Tagged knock-in of importins or cargo proteins with fluorescent or affinity tags enables real-time tracking and biochemical isolation of nuclear import complexes [4, 8]. Knock-in of disease mutations (e.g., SOD1) models impaired transport.
Overexpression
Overexpression of positive regulators such as ACSS2 or p300 can enhance nuclear import and drive downstream gene expression programs [3, 4]. This is useful for gain-of-function studies and therapeutic screening.
How EDITGENE Supports positive regulation of protein import into nucleus Research
Researchers studying positive regulation of protein import into nucleus-related genes often need to determine whether a candidate gene is causally involved in nuclear transport, how mutations alter cargo recognition, and whether modulating import activity changes disease phenotypes. EDITGENE provides CRISPR-based cell model services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein import into nucleus research.
Frequently Asked Questions About positive regulation of protein import into nucleus
What is GO:0042307?
GO:0042307 is the Gene Ontology term for positive regulation of protein import into nucleus, describing any process that increases the movement of proteins from the cytoplasm into the nucleus [1, 3].
What genes are involved in positive regulation of protein import into nucleus?
Key genes include ACSS2, STAT1, PKM2, PDIA3, p300, SOD1, NCBP3, and importins [3, 4, 5, 7, 8].
How is nuclear import positively regulated?
It is regulated by signals that modify cargo or importins, by chaperones like PDIA3, and by the RanGTP gradient [4, 5, 8].
What diseases are linked to defective nuclear import?
Cancer, ALS, Hutchinson-Gilford progeria syndrome, and chronic liver disease have been linked to altered nuclear import [2, 4, 6, 7].
What methods study positive regulation of protein import into nucleus?
Imaging, proteomics, RNA-seq, and CRISPR screens are commonly used [2, 3, 5, 8].
Can CRISPR knockout help study nuclear import?
Yes, knockout of candidate genes such as ACSS2 or PDIA3 can reveal their role in nuclear import [3, 5].
What is the role of PDIA3 in nuclear import?
PDIA3 acts as a chaperone to facilitate non-canonical nuclear import of STAT1 and PKM2.
How does mTORC1 regulate nuclear import?
mTORC1 hyperactivation alters p300 nucleocytoplasmic shuttling, affecting nuclear import.
Is nuclear import involved in autophagy?
Yes, nuclear ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy.
What CRISPR models are available for nuclear import research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening models [2, 3, 5, 8].
Conclusion
Positive regulation of protein import into nucleus (GO:0042307) is a central biological process that controls the delivery of cytoplasmic signals to the nucleus, influencing cell division, metabolism, immunity, and disease [1, 3, 5]. Dysregulation of this process is implicated in cancer, neurodegeneration, and premature aging [4, 6, 7]. CRISPR-based models and functional genomics screens provide powerful tools to dissect the regulatory mechanisms and identify therapeutic targets [2, 8]. EDITGENE supports researchers with comprehensive cell model and screening services to advance this field.
References
- 1. Yang W et al.. 2021. Molecular mechanism of cytokinin-activated cell division in Arabidopsis.. Science 371(6536):1350-1355 PMID: 33632892
- 2. Ng SWK et al.. 2021. Convergent somatic mutations in metabolism genes in chronic liver disease.. Nature 598(7881):473-478 PMID: 34646017
- 3. Li X et al.. 2017. Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.. Mol Cell 66(5):684-697.e9 PMID: 28552616
- 4. Son SM et al.. 2024. p300 nucleocytoplasmic shuttling underlies mTORC1 hyperactivation in Hutchinson-Gilford progeria syndrome.. Nat Cell Biol 26(2):235-249 PMID: 38267537
- 5. Yang CL et al.. 2024. PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2.. Mol Ther 32(8):2778-2797 PMID: 38822524
- 6. Wang Z. 2017. ErbB Receptors and Cancer.. Methods Mol Biol 1652:3-35 PMID: 28791631
- 7. Argueti-Ostrovsky S et al.. 2026. Impaired nucleocytoplasmic transport in SOD1-mediated ALS.. Mol Neurodegener 21(1):14 PMID: 41691309
- 8. Dou Y et al.. 2020. NCBP3 positively impacts mRNA biogenesis.. Nucleic Acids Res 48(18):10413-10427 PMID: 32960271
